LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
• To understand mechanisms of resistance to cancer immunotherapy
• To gain knowledge of novel strategies to overcome myeloid immunosuppression in prostate and other immune-refractory cancers.

Session date: 
02/24/2025 - 12:00pm to 1:00pm CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dr. Akash Patnaik